Both Januvia and Byetta, like most other diabetes medications, may cause hypoglycemia (low blood sugar)
With 90 degrees insertion, needles 4-5 mm enter the subcutaneous tissue with minimal risk of IM injection in virtually all adults
To view or add a comment, sign in The potential impact and diagnostic value of inflammatory markers on diabetic foot progression in type II diabetes mellitus: A casecontrol study - ScienceDirect To view or add a comment, sign in First Randomized Trial of Tirzepatide in T1D Shows Benefits Tirzepatide was shown to reduce body weight and insulin doses in adults with type 1 diabetes and obesity, according to a phase 2 trial
Plus, its an empowering, feel-good step to take your health into your own hands where possible
In a phase 3 trial, participants taking the highest dose of retatrutide lost an average of 28.7% of their body weight